Detecting Retinal Anomalies with
Intelligent Precision.
Glycosight is pioneering the future of clinical eyecare. We equip modern clinics with localized, highly precise AI frameworks to instantly detect Diabetic Retinopathy, preventing irreversible vision loss at scale.
A Scaling Healthcare Crisis.
By 2030, over 190 million people globally will suffer from Diabetic Retinopathy. Early detection saves 95% of patients from blindness, but manual grading of fundus imagery takes days. We process it in milliseconds.
Engineered natively for Ophthalmologists.
We handle the complex machine learning architecture entirely under the hood. No new hardware. No complicated setups.
Adaptive Image Clarity
Our backend automatically isolates algorithmic noise. Utilizing Contrast-Limited Equalization, uploaded imagery is instantly clarified for the neural engine.
Predictive Engine
Categorizes scans precisely into standard WHO diagnostic phases (Stages 0 - 4), allowing doctors to instantly triage patients based on severity.
Ironclad Data Privacy
Glycosight runs completely localized per clinic. Images never leave your hospital's secure network block. 100% HIPAA compliant by default.
Ready to elevate your clinical throughput?
Become an early adopter. Give your clinical staff the tools they need to protect patient vision faster than ever before.